the staff of the Ridgewood blog
PATERSON NJ, Trump Derangement Syndrome is propelling U.S. Rep. Bill Pascrell, Jr. (D-NJ-09) and Sen. Bob Menendez (D-NJ) who wrote to U.S. Food and Drug Administration (FDA) Commissioner Dr. Stephen Hahn calling on his agency to be guided by science and not “politics or political interference” in granting approvals for therapeutics to combat COVID-19.
Trump Derangement Syndrome is an affliction suffered by many President Trump haters . What ever the President says or does you have TDS makes you support the opposite . Examples include media praising North Korea, Iran and other assorted terrorist organizations around the world. And yes your death would be a small price to pay.
In the latest example long suffering U.S. Rep. Bill Pascrell, Jr. (D-NJ-09) and Sen. Bob Menendez (D-NJ) are attempting to interfere with treatment options for coronavirus treatment due to TDS.
On March 30th ,the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.
So here is the science :
HCQ has the ability to prevent the virus from entering the cell, as well as to prevent the virus from replicating. HCQ has the unique factor of being able to accumulate high concentrations in the lungs (specifically where it is needed). What is also appealing is the long duration (22 day half-life) of HCQ in the body. These factors make it promising for early treatment if ingested days before the virus is introduced.
After initially being downplayed by the media ,a Florida man diagnosed with coronavirus claims he was saved from certain death by an anti-malaria drug touted as a possible treatment by President Trump.
A recent French peer review study by renowned infectious disease specialist Dr. Didier Raoult which was published in the International Journal of Antimicrobial Agents showed promising results in the treatment of COVID-19 with Hydroxychloroquine (HCQ).
The French study also showed a significant decrease in “viral shedding,” from patients treated with HCQ. The lower the shedding, the less likelihood that the virus can be communicated to other individuals.
Building on his previous study world famous French infectious disease specialist Dr. Didier Raoult submitted an additional study of 60 patients treated with a combination of HCQ and Zithromax (Azithromycin is generic for Zithromax). Of the 80 patients, all but one survived.
Dr. Stephen Smith of the Smith Center for Infectious Diseases is treating all his patients with HCQ. No patient he treated has needed to be vented. Dr. Amesh Adalja uses HCQ only and has seen good results. Dr. Zev Zelenko claims to have treated 350 patients with zero deaths and zero hospitalizations.
The most interesting and hopeful broad-based development is the use of HCQ as a “preventative therapy.” Recently, almost 70 doctors, scientists and health care providers signed a letter encouraging the use and further study for HCQ to be used in the prevention of the spread of COVID-19.
Top Doctors Join State Senators Call to Use Hydroxychloroquine a Drugs Touted by the President to Combat Spread of COVID-19